Home › High Blood Pressure in Pregnancy › NCT06647511
Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women
Who can join
Ages 18 and older · Women · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Pregnant * Refugee, asylum seeking, or asylee as designated by the U.S. Government * Greater than or equal to 18 years of age * Has a personal smartphone Exclusion Criteria: * Unable to provide informed consent * Determined by the PI to be in an extremely vulnerable position and therefore not suited for research participation * Planned move from the New York City (NYC) area within the next 24 months
About the study
The goal of this observational study is to use digital health tracking to improve how high blood pressure and other health issues are detected in pregnant refugee women. The main questions this study aims to answer are are:
* Can a digital monitoring system that checks for high blood pressure in these women be tested and refined, using clinical training and validation? * Can this digital monitoring system accurately track any related pregnancy health issues and be used to refer participants to care providers? * Can this system be used to accurately identify risks associated with the contraction of pregnancy-related conditions, such as preeclampsia and high blood pressure?
Participants will:
* Complete baseline and follow-up in-person appointments; * Complete surveys at these appointment that track their health, stress levels, and comorbidities/risks associated with pregnancy; * Be given a smartwatch fitness tracker and electronic blood pressure cuffs for at-home measurements.
What is being tested
- Nokia-Withings BPM Connect Blood Pressure Monitor (device)
- Smartwatch Devices (device)
Sponsor: Weill Medical College of Cornell University · Participants: 75 · Started: Sep 12, 2024
Contact the study team
- Gunisha Kaur, MA, MD · Phone: (212) 746-2461
- Michele Steinkamp, RN · Phone: 2127462953
Official record on ClinicalTrials.gov — NCT06647511
Locations in the U.S.
| New York | Weill Cornell Medicine, New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.